Coralville, IA, United States of America

Mark Aaron Behlke

USPTO Granted Patents = 81 (Patent Applications = 52)

CIPO Patents = 3 (Patent Applications = 9)

EPO Patents = 24 (Patent Applications = 30)

Average Co-Inventor Count = 4.1

ph-index = 12

Forward Citations = 578(Granted Patents)

Forward Citations (Not Self Cited) = 435(Oct 12, 2025)

Inventors with similar research interests:

Location History:

Iowa City, IA (US) (2004 - 2006)
Coraville, IA (US) (2014)
Coralville, IA (US) (2005 - 2024)

Company Filing History:

72 out of 105

Integrated Dna Technologies, Inc.

University of Iowa Research Foundation

6. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2004-2025

Loading Chart...

81 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12454684 - Methods using novel CPF1 mutations that enhance the DNA cleavage activity ofsp. CPF1 (2025-10-28),

2. 12378612 - Oligonucleotide-based probes and methods for detection of microbes (2025-08-05),

3. 12351799 - S. pyogenes CAS9 mutant genes and polypeptides encoded by same (2025-07-08),

4. 12168765 - CAS9 mutant genes and polypeptides encoded by same (2024-12-17),

5. 12123033 - Modified double-stranded donor templates (2024-10-22),

6. 12024742 - RNASE H2 mutants that reduce primer dimers and off-target amplification in RHPCR-based amplicon sequencing with high-fidelity DNA polymerases (2024-07-02),

7. 12012433 - Expression and purification of Cas enzymes (2024-06-18),

8. 11999994 - Methods for production and quantification of unique molecular identifier-labeled beads (2024-06-04),

9. 11926866 - Method for detecting on-target and predicted off-target genome editing events (2024-03-12),

10. 11913014 - Cas9 mutant genes and polypeptides encoded by same (2024-02-27),

11. 11566283 - T-enhanced blocking oligonucleotides and baits for improved target enrichment and reduced off-target selection (2023-01-31),

12. 11566282 - T-enhanced blocking oligonucleotides and baits for improved target enrichment and reduced off-target selection (2023-01-31),

13. 11459559 - CRISPR-based compositions and methods of use (2022-10-04),

14. 11447758 - [object Object] (2022-09-20),

15. 11427818 - [object Object] (2022-08-30),

Title: The Innovative Journey of Mark Aaron Behlke

Introduction: Mark Aaron Behlke is a pioneering inventor based in Coralville, Iowa. With a passion for pushing the boundaries of science and technology, Behlke has made significant contributions to the field of innovation.

Latest Patents: Behlke holds several patents in the field of biotechnology and molecular biology, focusing on novel methods for gene expression analysis and nucleic acid detection. His recent patents showcase his commitment to advancing research in these critical areas.

Career Highlights: Throughout his career, Behlke has been at the forefront of cutting-edge research, working on groundbreaking projects that have the potential to revolutionize the way we approach genetic analysis. His innovative solutions have garnered recognition from peers in the industry.

Collaborations: Behlke has collaborated with leading research institutions and biotechnology companies to further develop and implement his inventions. His partnerships have been instrumental in bringing his ideas to life and making a tangible impact on the scientific community.

Conclusion: Mark Aaron Behlke's dedication to innovation and his relentless pursuit of scientific excellence have established him as a prominent figure in the world of biotechnology. His work continues to inspire and shape the future of genetic research.

This text is generated by artificial intelligence and may not be accurate.